Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.8, 2011-08, pp. : 963-979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Liu Nina O’Brien Susan

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 297-304

Humana Press, Inc

Access to resources Recommend Favorite

Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative Disorders: A Review

By Pangalis G.A. Dimopoulou M.N. Angelopoulou M.K. Tsekouras C. Vassilakopoulos T.P. Vaiopoulos G. Siakantaris M.P.

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 99-107

Humana Press, Inc

Access to resources Recommend Favorite

Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 258-267

Bentham Science Publishers

Access to resources Recommend Favorite

Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy

By Dillman R.O.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 465-471

Springer Publishing Company

Access to resources Recommend Favorite

Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 69-91

Future Medicine

Access to resources Recommend Favorite